1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Camrelizumab plus mFLOT regimen: new trials by email Literature Review of Camrelizumab plus mFLOT regimen trials Research Report on Camrelizumab plus mFLOT regimen
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Conversion Effects of PD-1 Antibody Camrelizumab Combined With Nab-POF Regimen Chemotherpy in Patients With Initially Unresectable Locally Advanced or Limited Metastatic Gastric or Gastroesophageal Junction Adenocarcinomaļ¼FDZL-GC001 Trial Camrelizumab plus mFLOT regimen, R0 surgery - Metastatic Gastric Cancer, Locally Advanced Gastric Adenocarcinoma | Phase 2 | Completed | Fudan University | 40 | 2021-01-06 | 2025-03-12 |
Fudan University (1)
China (1)